Companies / Oman
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
US-FTA Aiding Growth
May 2007 | Five Year ForecastsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Oman is regarded as having one of the most efficient healthcare systems in the Middle East & North Africa (MENA) region. This factor, alongside rapid population growth and the rising contribution of the private sector - much like in the rest of the Gulf Cooperation Council (GCC) - has driven a significant annual growth of the country''s pharmaceutical market. The private sector is primarily stimulated by the exclusion of expatriate workers from public healthcare schemes and the increased demand for medical tourism, with many patients now seeking cheaper, but still high-class, treatment in GCC hospitals rather than in the US